![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Lo Ho Yin
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.20, Iss.4, 2010-04, pp. : 459-469
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Advances in the design of ITK inhibitors
By Charrier Jean-Damien Knegtel Ronald MA
Expert Opinion on Drug Discovery, Vol. 8, Iss. 4, 2013-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tubulin inhibitors: a patent review
By Liu Yi-Min Chen Hsiao-Ling Lee Hsueh-Yun Liou Jing-Ping
Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 1, 2014-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Selectin inhibitors: a patent review
By Bedard Patricia W Kaila Neelu
Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 6, 2010-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Quorum sensing inhibitors: a patent review
Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. :